Layered double hydroxides (LDHs) are mixed M(II) and
M(III) hydroxides
with positively charged lamellar brucite layers and interlayered anions.
LDHs have attracted significant attention due to their anion- and
cation-exchange ability, adsorption capacity, and potential applications
in drug delivery and catalysis. The properties of LDHs directly correlate
with their structures. In this study, we synthesized nickel-aluminum
LDHs by the sol–gel method. We investigated the changes in
their crystal structure/morphology introduced by hydrothermal treatments
that varied from 0 to 48 h. Based on measured data using X-ray diffraction,
scanning electron microscopy, transmission electron microscopy, and
synchrotron-based small-angle X-ray scattering, we demonstrated that
the duration of the hydrothermal treatment can effectively control
the micro- and nanostructures of Ni–Al LDHs. We found that
the hydrothermal treatment leads to a two-step change in the structure
of the LDHs. In the first step, crystallization occurred during the
first 24 h of hydrothermal treatment, increasing the interlayer width
(from 2.28 to 2.31 nm) and the crystallite size (from 14.2 to 50.6
nm). In the second step, the predominant phenomena were stacking and
planar expansion after the crystallization process approached equilibrium.
Thus, the layered structure already developed in the first step was
further stacked, and the hexagonal platelet characteristic of LDH
expanded in a planar direction. Our study suggests that the duration
of the hydrothermal treatment is a crucial factor in the structural
evolution of LDHs and can be used to control the structure of LDHs
for different applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.